Concourse Financial Group Securities’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 3301 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4700 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4689 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4728 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4731 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 4671 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 4607 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 4542 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 4419 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 4391 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4191 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 4231 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 4169 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 4245 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4156 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 4037 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3943 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3858 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3701 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3596 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 3602 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 3560 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 3301 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 3590 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 3558 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 3438 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3057 |
|